News
Press ReleaseCell and gene therapy industry continues to expand manufacturing infrastructure in the UK
Selecting appropriate models for non-clinical studies of gene therapiesRegulatory Round-up - August 2023Cell and Gene Therapy Catapult, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapiesCell and Gene Therapy Catapult to support FourPlus in testing its immersive technology training platformPlasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogeneic cell immunotherapiesRegulatory Round-up - July 2023Cell and Gene Therapy Catapult appoints Jeanette Evans as Chief Business OfficerCell and Gene Therapy Catapult to support the development of NK:IO’s natural killer cell therapyThe Advanced Therapies Apprenticeship Community welcomes its 300th apprenticeRegulatory Round-up - June 2023Cell and Gene Therapy Catapult nominated for Innovation of the Year Award at the British Training AwardsAutolomous and the Cell and Gene Therapy Catapult awarded £1.2m grant by UK Research and Innovation